CY1106714T1 - Παραγωγα αλκυλικων αιθερων ή τα αλατα τους - Google Patents
Παραγωγα αλκυλικων αιθερων ή τα αλατα τουςInfo
- Publication number
- CY1106714T1 CY1106714T1 CY20071100909T CY071100909T CY1106714T1 CY 1106714 T1 CY1106714 T1 CY 1106714T1 CY 20071100909 T CY20071100909 T CY 20071100909T CY 071100909 T CY071100909 T CY 071100909T CY 1106714 T1 CY1106714 T1 CY 1106714T1
- Authority
- CY
- Cyprus
- Prior art keywords
- group
- action
- integer
- ring
- alkyl ether
- Prior art date
Links
- 150000005215 alkyl ethers Chemical class 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 210000002241 neurite Anatomy 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 210000000578 peripheral nerve Anatomy 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Ένα παράγωγο αλκυλικού αιθέρα (αλκυλαιθέρα) που αντιπροσωπεύεται από το γενικό χημικό τύπο (δες σχέδιο) όπου το καθένα των R1 και R2 αντιπροσωπεύει μία ή περισσότερες ομάδες που επιλέγονται από ένα άτομο υδρογόνου, ένα άτομο αλογόνου, μια αλκυλομάδα, μια αρυλομάδα, μια αραλκυλομάδα, μια αλκοξυομάδα, μια αρυλοξυομάδα, μια ομάδα αλκυλοθείου, μια ομάδα αρυλοθείου, μια ομάδα αλκενυλίου, μια αλκενυλοξυομάδα, μια αμινομάδα, μια ομάδα αλκυλοσουλφονυλίου, μια ομάδα αρυλοσουλφονυλίου, μια ομάδα καρβαμοϋλίου, μια ετεροκυκλική ομάδα, μια ομάδα υδροξυλίου, μια ομάδα καρβοξυλίου, μια νιτροομάδα, μια οξοομάδα και τα παρόμοια το R3 είναι μια αλκυλαμινομάδα, μια αμινομάδα, μια υδροξυλομάδα ή τα συναφή• ο δακτύλιος Α είναι ένας 5-μελής ή 6-μελής ετεροαρωματικός δακτύλιος ή ένας δακτύλιος βενζενίου το καθένα των m και n είναι ένας ακέραιος από 1 έως 6 και το p είναι ένας ακέραιος από 1 έως 3, ή ένα άλας του, έχει τη δράση να προστατεύει νευρώνες, τη δράση να επιταχύνει την αναγέννηση των νεύρων και τη δράση να επιταχύνει την επέκταση των νευριτών και ως εκ τούτου είναι χρήσιμο σαν ένας θεραπευτικός παράγοντας για ασθένειες στα κεντρικά και περιφερικά νεύρα.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001321381 | 2001-10-19 | ||
| PCT/JP2002/010827 WO2003035647A1 (fr) | 2001-10-19 | 2002-10-18 | Derives ou sels d'ether d'alkyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106714T1 true CY1106714T1 (el) | 2012-05-23 |
Family
ID=19138603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100909T CY1106714T1 (el) | 2001-10-19 | 2007-07-09 | Παραγωγα αλκυλικων αιθερων ή τα αλατα τους |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US7087594B2 (el) |
| EP (1) | EP1437353B1 (el) |
| JP (1) | JP4398247B2 (el) |
| KR (1) | KR100956990B1 (el) |
| CN (2) | CN100500662C (el) |
| AT (1) | ATE364604T1 (el) |
| AU (1) | AU2002344107B2 (el) |
| BR (1) | BRPI0213393B8 (el) |
| CA (1) | CA2464358C (el) |
| CY (1) | CY1106714T1 (el) |
| DE (1) | DE60220694T2 (el) |
| DK (1) | DK1437353T3 (el) |
| ES (1) | ES2287324T3 (el) |
| HU (1) | HU230407B1 (el) |
| IL (2) | IL161308A0 (el) |
| MX (1) | MXPA04003541A (el) |
| NO (1) | NO325780B1 (el) |
| NZ (1) | NZ532328A (el) |
| PL (2) | PL215264B1 (el) |
| PT (1) | PT1437353E (el) |
| RO (1) | RO122203B1 (el) |
| WO (1) | WO2003035647A1 (el) |
| ZA (1) | ZA200402806B (el) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU230407B1 (hu) * | 2001-10-19 | 2016-04-28 | Toyama Chemical Co., Ltd. | Alkil-éter-származékok és sóik |
| MXPA04012534A (es) | 2002-06-14 | 2005-04-19 | Toyama Chemical Co Ltd | Composicion farmaceutica para mejorar la funcion cerebral y metodo para mejorar la funcion cerebral. |
| US20060205709A1 (en) * | 2003-04-17 | 2006-09-14 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| AU2011204959B2 (en) * | 2005-03-28 | 2012-04-12 | Toyama Chemical Co., Ltd. | Process for production of 1-(3-(2-(1-benzothiophen-5-YL)- ethoxy)propyl)azetidin-3-ol or salts thereof |
| EP2248809B1 (en) | 2005-03-28 | 2012-05-09 | Toyama Chemical Co., Ltd. | Alkyl-3-[2-(benzo[b]thiophen-5-yl)-ethoxy]-propanoates as intermediates in the production of Azetidin-3-ol derivatives |
| JP4902247B2 (ja) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | ２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体 |
| JP2006328058A (ja) * | 2005-04-27 | 2006-12-07 | Toyama Chem Co Ltd | ２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体 |
| JP5695293B2 (ja) * | 2006-04-26 | 2015-04-01 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩を含有する神経細胞新生誘導剤および精神障害治療剤 |
| US8119625B2 (en) | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| JP5255441B2 (ja) * | 2006-08-04 | 2013-08-07 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩を含有するプロテインキナーゼｃ活性促進剤 |
| NZ589448A (en) | 2008-05-28 | 2011-09-30 | Toyama Chemical Co Ltd | Novel benzothiophene oxide derivative and salt thereof |
| PL2818165T3 (pl) | 2012-02-22 | 2019-09-30 | Fujifilm Toyama Chemical Co., Ltd. | Stała kompozycja farmaceutyczna zawierająca 1-(3-(2-(1-benzotiofen-5-ylo)etoksy)propylo)-azetydyn-3-ol albo jego sól |
| AU2015211753B2 (en) | 2014-01-31 | 2019-09-12 | Fujifilm Toyama Chemical Co., Ltd. | Post nerve injury rehabilitation effect-enhancing agent comprising alkyl ether derivative or salt thereof |
| WO2016199878A1 (ja) * | 2015-06-11 | 2016-12-15 | 富山化学工業株式会社 | シグマ受容体結合剤 |
| KR20180097581A (ko) | 2015-12-25 | 2018-08-31 | 토야마 케미칼 컴퍼니 리미티드 | 1-(3-(2-(1-벤조티오펜-5-일)에톡시)프로필)아제티딘-3-올 또는 그 염을 포함하는 정제 |
| WO2018124284A1 (ja) | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | 医薬組成物 |
| JP7057286B2 (ja) | 2016-12-28 | 2022-04-19 | 富士フイルム富山化学株式会社 | 医薬組成物 |
| EP3563843A4 (en) * | 2016-12-28 | 2019-12-11 | FUJIFILM Toyama Chemical Co., Ltd. | TOPICAL COMPOSITION |
| WO2018124282A1 (ja) | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | 医薬組成物およびその製造方法 |
| CN116492335A (zh) | 2017-06-02 | 2023-07-28 | 富士胶片富山化学株式会社 | 脑萎缩预防或治疗剂 |
| CA3067458C (en) | 2017-06-02 | 2022-11-01 | Fujifilm Toyama Chemical Co., Ltd. | Agent for reducing amount of amyloid .beta. protein |
| EP3636262A4 (en) | 2017-06-02 | 2020-06-10 | FUJIFILM Toyama Chemical Co., Ltd. | AGENT FOR PREVENTING OR TREATING ALZHEIMER-LIKE DEMENTIA |
| EP3632430A4 (en) | 2017-06-02 | 2020-06-10 | FUJIFILM Toyama Chemical Co., Ltd. | AGENT FOR THE PREVENTION OR TREATMENT OF SPINOCEREBELLOUS ATAXIA |
| JP7370859B2 (ja) | 2017-06-02 | 2023-10-30 | 富士フイルム富山化学株式会社 | タウオパチー予防または治療剤 |
| EP3705121B1 (en) * | 2017-10-30 | 2023-08-30 | FUJIFILM Toyama Chemical Co., Ltd. | Emopamil binding protein binding agent and use thereof |
| CN114853619B (zh) * | 2022-05-19 | 2024-05-10 | 神隆医药（常熟）有限公司 | 一种适于工业化生产的n-甲基酪胺盐酸盐的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01156973A (ja) | 1987-09-04 | 1989-06-20 | Tanabe Seiyaku Co Ltd | ベンゾフラン誘導体 |
| JP2887492B2 (ja) | 1990-02-05 | 1999-04-26 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| JP3044055B2 (ja) | 1990-08-09 | 2000-05-22 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| DK74693D0 (da) | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| JP3232830B2 (ja) | 1993-11-30 | 2001-11-26 | 三菱電機株式会社 | フレキシブルディスク装置のキャリッジ機構 |
| JPH08268883A (ja) | 1994-10-25 | 1996-10-15 | Toyama Chem Co Ltd | １−フェニル−１，２−エタンジオール誘導体またはそ の塩を含有する神経成長因子の作用増強剤 |
| KR100447738B1 (ko) | 1994-10-25 | 2005-09-20 | 도야마 가가쿠 고교 가부시키가이샤 | 1,2-에탄디올유도체또는그의염을함유한의약조성물 |
| CN1615861A (zh) | 1995-08-11 | 2005-05-18 | 美国辉瑞有限公司 | （1s，2s）－1－（4－羟基苯基）－2－（4－羟基－4－苯基哌啶－1－基）－1－丙醇甲磺酸盐三水合物 |
| AU7001796A (en) | 1995-09-22 | 1997-04-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and medicinal use thereof |
| DE19605610A1 (de) | 1996-02-15 | 1997-08-21 | Hoechst Ag | Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| WO1997030703A1 (fr) | 1996-02-20 | 1997-08-28 | Toyama Chemical Co., Ltd. | Agent ameliorant les fonctions cerebrales contenant des derives de 1,2-ethanediol ou des sels de celui-ci |
| JP4549452B2 (ja) | 1997-12-12 | 2010-09-22 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤 |
| AU1506499A (en) * | 1997-12-12 | 1999-07-05 | Toyama Chemical Co. Ltd. | Alkyl ether derivatives or salts thereof and calcium antagonists containing the same |
| DK1186594T3 (da) | 1999-06-11 | 2009-09-14 | Toyama Chemical Co Ltd | N-alkoxylkyl-N,N-dialkylamin-derivater eller salte deraf og midler mod neurodegenerative sygdomme, som indeholder disse |
| HU230407B1 (hu) | 2001-10-19 | 2016-04-28 | Toyama Chemical Co., Ltd. | Alkil-éter-származékok és sóik |
| MXPA04012534A (es) | 2002-06-14 | 2005-04-19 | Toyama Chemical Co Ltd | Composicion farmaceutica para mejorar la funcion cerebral y metodo para mejorar la funcion cerebral. |
| US20060205709A1 (en) | 2003-04-17 | 2006-09-14 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| EP2248809B1 (en) | 2005-03-28 | 2012-05-09 | Toyama Chemical Co., Ltd. | Alkyl-3-[2-(benzo[b]thiophen-5-yl)-ethoxy]-propanoates as intermediates in the production of Azetidin-3-ol derivatives |
| JP5695293B2 (ja) | 2006-04-26 | 2015-04-01 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩を含有する神経細胞新生誘導剤および精神障害治療剤 |
| US8119625B2 (en) | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| JP5255441B2 (ja) | 2006-08-04 | 2013-08-07 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩を含有するプロテインキナーゼｃ活性促進剤 |
| NZ589448A (en) | 2008-05-28 | 2011-09-30 | Toyama Chemical Co Ltd | Novel benzothiophene oxide derivative and salt thereof |
-
2002
- 2002-10-18 HU HU0500017A patent/HU230407B1/hu unknown
- 2002-10-18 BR BRPI0213393A patent/BRPI0213393B8/pt not_active IP Right Cessation
- 2002-10-18 RO ROA200400354A patent/RO122203B1/ro unknown
- 2002-10-18 US US10/492,774 patent/US7087594B2/en not_active Ceased
- 2002-10-18 AT AT02777882T patent/ATE364604T1/de active
- 2002-10-18 WO PCT/JP2002/010827 patent/WO2003035647A1/ja active IP Right Grant
- 2002-10-18 DE DE60220694T patent/DE60220694T2/de not_active Expired - Lifetime
- 2002-10-18 CA CA2464358A patent/CA2464358C/en not_active Expired - Lifetime
- 2002-10-18 NZ NZ532328A patent/NZ532328A/en not_active IP Right Cessation
- 2002-10-18 PL PL369601A patent/PL215264B1/pl unknown
- 2002-10-18 IL IL16130802A patent/IL161308A0/xx unknown
- 2002-10-18 KR KR1020047005687A patent/KR100956990B1/ko active IP Right Grant
- 2002-10-18 CN CNB028206452A patent/CN100500662C/zh not_active Expired - Lifetime
- 2002-10-18 PL PL402986A patent/PL217872B1/pl unknown
- 2002-10-18 MX MXPA04003541A patent/MXPA04003541A/es active IP Right Grant
- 2002-10-18 JP JP2003538163A patent/JP4398247B2/ja not_active Expired - Lifetime
- 2002-10-18 ES ES02777882T patent/ES2287324T3/es not_active Expired - Lifetime
- 2002-10-18 DK DK02777882T patent/DK1437353T3/da active
- 2002-10-18 AU AU2002344107A patent/AU2002344107B2/en not_active Expired
- 2002-10-18 EP EP02777882A patent/EP1437353B1/en not_active Expired - Lifetime
- 2002-10-18 CN CN2009102038534A patent/CN101643470B/zh not_active Expired - Lifetime
- 2002-10-18 PT PT02777882T patent/PT1437353E/pt unknown
- 2002-10-18 US US13/327,152 patent/USRE43676E1/en not_active Expired - Lifetime
-
2004
- 2004-04-07 IL IL161308A patent/IL161308A/en active IP Right Grant
- 2004-04-13 ZA ZA2004/02806A patent/ZA200402806B/en unknown
- 2004-04-15 NO NO20041531A patent/NO325780B1/no not_active IP Right Cessation
-
2006
- 2006-05-03 US US11/416,321 patent/US7468443B2/en not_active Expired - Lifetime
-
2007
- 2007-07-09 CY CY20071100909T patent/CY1106714T1/el unknown
-
2008
- 2008-10-17 US US12/253,379 patent/US8129535B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106714T1 (el) | Παραγωγα αλκυλικων αιθερων ή τα αλατα τους | |
| CY1108019T1 (el) | Ενωσεις πυριμιδινης | |
| CY1117132T1 (el) | Παραγωγο θειαζολιου | |
| AR035548A1 (es) | Compuestos organicos | |
| CY1106858T1 (el) | Νεα παραγωγα κυκλικου αμιδιου | |
| CY1107978T1 (el) | Νeα παρaγωγα πυριδαζiν -3 (2h) - oνης | |
| ATE264846T1 (de) | Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen | |
| HUP0402313A2 (hu) | Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
| HUP0204587A2 (en) | 6-position substituted indoline, production and use thereof as a medicament | |
| ATE448226T1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
| CY1107915T1 (el) | Τρικυκλικες σπιροπιπεριδινες ή σπιροπυρρολιδινες | |
| CY1108313T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
| KR960004344A (ko) | 6원 질소 함유 헤테로아릴-옥사졸리디논 | |
| AR036107A1 (es) | Derivados de 6-fenilpirrolpirimidindiona, antagonista de los receptores a2 de la adenosina, particularmente del subtipo a2, de aplicacion en la prevencion de la degranulacion de los mastocitos; composiciones farmaceuticas formuladas con dichos compuestos y uso de los mismos en la preparacion de medi | |
| CY1107509T1 (el) | Αμινοθειαζολες ως αναστολεις κυκλινη - εξαρτωμενων κινασεων | |
| DE69624437D1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
| CY1115643T1 (el) | Διεγερτης νευρογενεσης ή θεραπευτικος παραγων νευροπαθειας που περιλαμβανει παραγωγα αλκυλ αιθερα ή αλας αυτου | |
| HUP0101595A2 (hu) | 3-(Amino- vagy amino-alkil)-piridinon-származékok, eljárás előállításukra és alkalmazásuk HIV-vel kapcsolatos betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| DK0649418T3 (da) | 7-(2-aminoethyl)benzothiazolon | |
| IT1315267B1 (it) | Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale | |
| SE9703378D0 (sv) | New compounds | |
| KR880001650A (ko) | 트리아졸로피리딘 또는 트리아졸로퀴놀린의 신규 아미노알킬티오 유도체, 그의 제조방법 및 특히 진통제로서 유용한 그것이 존재하는 약제 | |
| MX9400253A (es) | Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| SE7712630L (sv) | Forfarande for framstellning av o-alkylerade hydroxylaminer |